PRE 14A

PRE 14A Filing

Company: Eloxx Pharmaceuticals, Inc.
Filed: October 18, 2011
Period of Report: October 18, 2011
Accession Number: 0001144204-11-058331

View Document ↗ View on SEC.gov ↗